Fundamentalpharma GmbH
From EverybodyWiki Bios & Wiki
FundaMental Pharma GmbH was founded in 2016. It is a biotech spinoff of Heidelberg University.[1].
FMP scientists have discovered the protective effects of VEGFD and NMDAR/TRPM4 interface inhibitors in mice models of stroke.[2][3]
References
- ↑ "FundaMental Pharma". Fundamentalpharma GmbH.
- ↑ "Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants". Science. 370 (6513): eaay3302. 9 October 2020. doi:10.1126/science.aay3302. PMID 33033186 Check
|pmid=value (help). - ↑ Mauceri, D; Buchthal, B; Hemstedt, TJ; Weiss, U; Klein, CD; Bading, H (14 April 2020). "Nasally delivered VEGFD mimetics mitigate stroke-induced dendrite loss and brain damage". Proceedings of the National Academy of Sciences of the United States of America. 117 (15): 8616–8623. doi:10.1073/pnas.2001563117. PMID 32229571 Check
|pmid=value (help).
This article "Fundamentalpharma GmbH" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Fundamentalpharma GmbH. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
